Cargando…

Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson’s disease

Intraneuronal inclusions of misfolded α-synuclein (α-syn) and prion-like spread of the pathologic α-syn contribute to progressive neuronal death in Parkinson’s disease (PD). Despite the pathologic significance, no efficient therapeutic intervention targeting α-synucleinopathy has been developed. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yunseon, Song, Jae-Jin, Choi, Yu Ree, Kim, Seong-hoon, Seok, Min-Jong, Wulansari, Noviana, Darsono, Wahyu Handoko Wibowo, Kwon, Oh-Chan, Chang, Mi-Yoon, Park, Sang Myun, Lee, Sang-Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2022
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304026/ https://www.ncbi.nlm.nih.gov/pubmed/35858361 http://dx.doi.org/10.1073/pnas.2110746119

Ejemplares similares

Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson’s disease-linked DNAJC6 mutations
por: Wulansari, Noviana, et al.
Publicado: (2021)

Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease
por: Wulansari, Noviana, et al.
Publicado: (2017)

SGK1 inhibition in glia ameliorates pathologies and symptoms in Parkinson disease animal models
por: Kwon, Oh‐Chan, et al.
Publicado: (2021)

Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson’s disease
por: Park, Soo Jin, et al.
Publicado: (2021)

The Synucleins and the Astrocyte
por: Myers, Abigail J., et al.
Publicado: (2023)

Amelioration of pathologic α-synuclein-induced Parkinson’s disease by irisin
por: Kam, Tae-In, et al.
Publicado: (2022)

Monitoring α-synuclein Aggregation Induced by Preformed α-synuclein Fibrils in an In Vitro Model System
por: Kim, Beom Jin, et al.
Publicado: (2023)

α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis
por: Wang, Pan, et al.
Publicado: (2023)

Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
por: Lee, Jee Hoon, et al.
Publicado: (2019)

Age-related increase in caveolin-1 expression facilitates cell-to-cell transmission of α-synuclein in neurons
por: Ha, Tae-Young, et al.
Publicado: (2021)

DJ-1 deficiency impairs glutamate uptake into astrocytes via the regulation of flotillin-1 and caveolin-1 expression
por: Kim, Jin-Mo, et al.
Publicado: (2016)

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
por: Fitzgerald, Emily, et al.
Publicado: (2019)

Initiation and progression of α-synuclein pathology in Parkinson’s disease
por: Tofaris, George K.
Publicado: (2022)

Astrocyte dysfunction in Parkinson's disease: from the perspectives of transmitted α-synuclein and genetic modulation
por: Wang, Changjing, et al.
Publicado: (2021)

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
por: Streubel-Gallasch, Linn, et al.
Publicado: (2021)

Microglia and astrocyte activation is region‐dependent in the α‐synuclein mouse model of Parkinson's disease
por: Basurco, Leyre, et al.
Publicado: (2022)

Gastrointestinal Biopsies for the Diagnosis of Alpha-Synuclein Pathology in Parkinson's Disease
por: Cersosimo, Maria Graciela
Publicado: (2015)

Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
por: Wang, Rui, et al.
Publicado: (2022)

Optogenetic induction of alpha-synuclein aggregation in human dopaminergic neurons to model Parkinson’s disease pathology
por: Ra, Eun A., et al.
Publicado: (2023)

Astrocytic expression of Parkinson's disease-related A53T α-synuclein causes neurodegeneration in mice
por: Gu, Xing-Long, et al.
Publicado: (2010)

Dementia in Parkinson's Disease Correlates with α-Synuclein Pathology but Not with Cortical Astrogliosis
por: van den Berge, Simone A., et al.
Publicado: (2012)

Identifying the Pathological Domain of Alpha- Synuclein as a Therapeutic for Parkinson’s Disease
por: Shen, Ning, et al.
Publicado: (2019)

Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology
por: Yuan, Xin, et al.
Publicado: (2022)

D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model
por: Kim, Donghoon, et al.
Publicado: (2018)

Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
por: Yun, Seung Pil, et al.
Publicado: (2018)

Evaluation of target volume and dose accuracy in intrafractional cases of lung cancer based on 4D-CT and 4D-CBCT images using an in-house dynamic thorax phantom
por: Haqqi, Firyal Dhiyaul, et al.
Publicado: (2022)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?
por: Zaltieri, Michela, et al.
Publicado: (2015)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

Functionally different α-synuclein inclusions yield insight into Parkinson’s disease pathology
por: Raiss, Christian C., et al.
Publicado: (2016)

Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease
por: Bi, Mingxia, et al.
Publicado: (2021)

Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
por: Guo, Mengyuan, et al.
Publicado: (2022)

Erratum to: PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAPpositive astrocytes
por: Choi, Insup, et al.
Publicado: (2016)

The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
por: Schulz-Schaeffer, Walter J.
Publicado: (2010)

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease
por: Shim, Kyu Hwan, et al.
Publicado: (2022)

MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
por: Mallajosyula, Jyothi K., et al.
Publicado: (2008)

PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes
por: Choi, Insup, et al.
Publicado: (2016)

Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease
por: Jin, Uram, et al.
Publicado: (2019)

Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
por: Sheng, Lifu, et al.
Publicado: (2020)

Novel Nasal Epithelial Cell Markers of Parkinson’s Disease Identified Using Cells Treated with α-Synuclein Preformed Fibrils
por: Kim, Hyojung, et al.
Publicado: (2020)

Clinical Neuropathology image 5-2014: α-synuclein pathology in the ependyma in Parkinson’s disease
por: Kovacs, Gabor
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c54d3j3v9s5i3mmommrchg1jja